Editorial Volume 14, Issue 14 pp 5612—5613
Metformin and breast cancer: an opportunity for pharmacogenetics
- 1 Metabolism and Cancer Group, Program Against Cancer Therapeutic Resistance, Catalan Institute of Oncology–Girona Biomedical Research Institute, Girona, Spain
- 2 Clinical Research Unit, Catalan Institute of Oncology–Girona, Girona, Spain
* On behalf of the METTEN study group
Received: June 7, 2022 Published: July 18, 2022
https://doi.org/10.18632/aging.204180How to Cite
Copyright: © 2022 Cuyàs et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.